Connecticut’s comptroller explains his thinking about GLP-1s for state employees

In this OpEd for STAT, Comptroller Scanlon discusses the challenges his office faced in covering GLP-1s and other anti-obesity medications and why they selected Intellihealth to help combat them.

Read more at STAT